BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34944053)

  • 1. Activation of Downstream mTORC1 Target Ribosomal Protein S6 Kinase (S6K) Can Be Found in a Subgroup of Dutch Patients with Granulomatous Pulmonary Disease.
    Kraaijvanger R; Seldenrijk K; Beijer E; Damen J; Wilson JL; Weichhart T; Grutters JC; Veltkamp M
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serine 302 Phosphorylation of Mouse Insulin Receptor Substrate 1 (IRS1) Is Dispensable for Normal Insulin Signaling and Feedback Regulation by Hepatic S6 Kinase.
    Copps KD; Hançer NJ; Qiu W; White MF
    J Biol Chem; 2016 Apr; 291(16):8602-17. PubMed ID: 26846849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTORC1-S6K activation by endotoxin contributes to cytokine up-regulation and early lethality in animals.
    Lee PS; Wilhelmson AS; Hubner AP; Reynolds SB; Gallacchi DA; Chiou TT; Kwiatkowski DJ
    PLoS One; 2010 Dec; 5(12):e14399. PubMed ID: 21200439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular tumors have increased p70 S6-kinase activation and are inhibited by topical rapamycin.
    Du W; Gerald D; Perruzzi CA; Rodriguez-Waitkus P; Enayati L; Krishnan B; Edmonds J; Hochman ML; Lev DC; Phung TL
    Lab Invest; 2013 Oct; 93(10):1115-27. PubMed ID: 23938603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition.
    Ito H; Ichiyanagi O; Naito S; Bilim VN; Tomita Y; Kato T; Nagaoka A; Tsuchiya N
    BMC Cancer; 2016 Jul; 16():393. PubMed ID: 27387559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Granulomatous diseases and pathogenic microorganism].
    Inoue Y; Suga M
    Kekkaku; 2008 Feb; 83(2):115-30. PubMed ID: 18326339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ghrelin-induced food intake and adiposity depend on central mTORC1/S6K1 signaling.
    Stevanovic D; Trajkovic V; Müller-Lühlhoff S; Brandt E; Abplanalp W; Bumke-Vogt C; Liehl B; Wiedmer P; Janjetovic K; Starcevic V; Pfeiffer AF; Al-Hasani H; Tschöp MH; Castañeda TR
    Mol Cell Endocrinol; 2013 Dec; 381(1-2):280-90. PubMed ID: 23994018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
    J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activation mechanism of plant S6 kinase (S6K), a substrate of TOR kinase, is different from that of mammalian S6K.
    Yaguchi M; Ikeya S; Kozaki A
    FEBS Lett; 2020 Feb; 594(4):776-787. PubMed ID: 31705659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression.
    Linke M; Pham HT; Katholnig K; Schnöller T; Miller A; Demel F; Schütz B; Rosner M; Kovacic B; Sukhbaatar N; Niederreiter B; Blüml S; Kuess P; Sexl V; Müller M; Mikula M; Weckwerth W; Haschemi A; Susani M; Hengstschläger M; Gambello MJ; Weichhart T
    Nat Immunol; 2017 Mar; 18(3):293-302. PubMed ID: 28092373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond controlling cell size: functional analyses of S6K in tumorigenesis.
    Wu X; Xie W; Xie W; Wei W; Guo J
    Cell Death Dis; 2022 Jul; 13(7):646. PubMed ID: 35879299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquilin-mediated Small Molecule Inhibition of Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling.
    Coffey RT; Shi Y; Long MJ; Marr MT; Hedstrom L
    J Biol Chem; 2016 Mar; 291(10):5221-33. PubMed ID: 26740621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistently Elevated mTOR Complex 1-S6 Kinase 1 Disrupts DARPP-32-Dependent D
    Lin R; Learman LN; Na CH; Renuse S; Chen KT; Chen PY; Lee GH; Xiao B; Resnick SM; Troncoso JC; Szumlinski KK; Linden DJ; Park JM; Savonenko A; Pandey A; Worley PF
    Biol Psychiatry; 2021 Jun; 89(11):1058-1072. PubMed ID: 33353667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p70 S6 kinase as a therapeutic target in cancers: More than just an mTOR effector.
    Artemenko M; Zhong SSW; To SKY; Wong AST
    Cancer Lett; 2022 Jun; 535():215593. PubMed ID: 35176419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCTP protein degradation by targeting mTORC1 and signaling through S6K, Akt, and Plk1 sensitizes lung cancer cells to DNA-damaging drugs.
    Jeong M; Jeong MH; Kim JE; Cho S; Lee KJ; Park S; Sohn J; Park YG
    Sci Rep; 2021 Oct; 11(1):20812. PubMed ID: 34675258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Luteinizing hormone/human chorionic gonadotropin-mediated activation of mTORC1 signaling is required for androgen synthesis by theca-interstitial cells.
    Palaniappan M; Menon KM
    Mol Endocrinol; 2012 Oct; 26(10):1732-42. PubMed ID: 22827930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuritic complexity of hippocampal neurons depends on WIP-mediated mTORC1 and Abl family kinases activities.
    Franco-Villanueva A; Wandosell F; Antón IM
    Brain Behav; 2015 Nov; 5(11):e00359. PubMed ID: 26664784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An mTORC1-Dependent Mouse Model for Cardiac Sarcoidosis.
    Bueno-Beti C; Lim CX; Protonotarios A; Szabo PL; Westaby J; Mazic M; Sheppard MN; Behr E; Hamza O; Kiss A; Podesser BK; Hengstschläger M; Weichhart T; Asimaki A
    J Am Heart Assoc; 2023 Oct; 12(19):e030478. PubMed ID: 37750561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin reverses pulmonary artery smooth muscle cell proliferation in pulmonary hypertension.
    Houssaini A; Abid S; Mouraret N; Wan F; Rideau D; Saker M; Marcos E; Tissot CM; Dubois-Randé JL; Amsellem V; Adnot S
    Am J Respir Cell Mol Biol; 2013 May; 48(5):568-77. PubMed ID: 23470622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of mTOR/S6K But Not MAPK Pathways Might Be Associated With High Ki-67, ER(+), and HER2(-) Breast Cancer.
    Yanai A; Inoue N; Yagi T; Nishimukai A; Miyagawa Y; Murase K; Imamura M; Enomoto Y; Takatsuka Y; Watanabe T; Hirota S; Sasa M; Katagiri T; Miyoshi Y
    Clin Breast Cancer; 2015 Jun; 15(3):197-203. PubMed ID: 25600244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.